loadpatents
name:-0.023040056228638
name:-0.017834901809692
name:-0.0011000633239746
Critical Outcome Technologies Inc. Patent Filings

Critical Outcome Technologies Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Critical Outcome Technologies Inc..The latest application filed is for "compounds and method for treatment of hiv".

Company Profile
0.19.14
  • Critical Outcome Technologies Inc. - London N/A CA
  • Critical Outcome Technologies Inc. - CA CA
  • Critical Outcome Technologies Inc. - London-Ontario CA
  • Critical Outcome Technologies, Inc. - Ontario CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds and method for treatment of HIV
Grant 9,624,220 - Danter , et al. April 18, 2
2017-04-18
Compounds And Method For Treatment Of Hiv
App 20160333010 - Danter; Wayne ;   et al.
2016-11-17
Compounds and method for treatment of HIV
Grant 9,422,282 - Danter , et al. August 23, 2
2016-08-23
Inhibitor compounds and cancer treatment methods
Grant 9,284,275 - Danter March 15, 2
2016-03-15
Compounds and method for treatment of HIV
Grant 8,987,272 - Danter , et al. March 24, 2
2015-03-24
Programmable Cell Model For Determining Cancer Treatments
App 20150019190 - Danter; Wayne R.
2015-01-15
Compounds and method for treatment of cancer
Grant 8,895,556 - Danter , et al. November 25, 2
2014-11-25
Compounds and method for treatment of cancer
Grant 8,822,475 - Danter , et al. September 2, 2
2014-09-02
Inhibitor Compounds and Cancer Treatment Methods
App 20140072555 - Danter; Wayne R.
2014-03-13
Inhibitor compounds and cancer treatment methods
Grant 8,580,792 - Danter November 12, 2
2013-11-12
Compounds and Method for Treatment of Cancer
App 20130231345 - Danter; Wayne R. ;   et al.
2013-09-05
Compounds and Method for Treatment of Cancer
App 20130165449 - Danter; Wayne R. ;   et al.
2013-06-27
Compounds and method for treatment of cancer
Grant 8,466,151 - Danter , et al. June 18, 2
2013-06-18
Compounds and method for treatment of cancer
Grant 8,420,643 - Danter , et al. April 16, 2
2013-04-16
Compounds and method for treatment of cancer
Grant 8,367,675 - Danter , et al. February 5, 2
2013-02-05
Inhibitor Compounds and Cancer Treatment Methods
App 20120195887 - Danter; Wayne R.
2012-08-02
Compounds And Method For Treatment Of Cancer
App 20120077820 - Danter; Wayne R. ;   et al.
2012-03-29
Inhibitor compounds and cancer treatment methods
Grant 8,138,191 - Danter March 20, 2
2012-03-20
Compounds And Method For Treatment Of Cancer
App 20110281887 - Danter; Wayne R. ;   et al.
2011-11-17
Compounds and method for treatment of cancer
Grant 8,034,815 - Danter , et al. October 11, 2
2011-10-11
Compounds And Method For Treatment Of Cancer
App 20110152281 - Danter; Wayne R. ;   et al.
2011-06-23
Inhibitor Compounds and Cancer Treatment Methods
App 20100015140 - Danter; Wayne R.
2010-01-21
Protein tyrosine kinase inhibitors
Grant 7,629,347 - Danter , et al. December 8, 2
2009-12-08
Protein Tyrosine Kinase Inhibitors
App 20090298855 - Danter; Wayne R. ;   et al.
2009-12-03
Protein tyrosine kinase inhibitors
Grant 7,585,866 - Danter , et al. September 8, 2
2009-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed